FDA: Page 76


  • FDA proposes alternative 510(k) criteria for MRI coils

    The draft guidance would permit manufacturers to use a set of performance criteria to demonstrate substantial equivalence, instead of a direct comparison to a predicate device.

    By Dec. 9, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    House bill would speed CMS coverage for breakthrough medtech

    The bipartisan legislation, reintroduced on Friday, promises faster access to new medical technologies by requiring Medicare to cover devices approved through FDA's breakthrough pathway during a three-year transitional period.

    By Dec. 9, 2019
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Impeachment clouds year-end medical device tax repeal, industry priorities

    AdvaMed argues the primary obstacle to repealing the tax is not the revenue the government would no longer collect, but a crowded year-end legislative agenda and impeachment proceedings against President Donald Trump.

    By David Lim • Dec. 9, 2019
  • Image attribution tooltip
    Kendall Davis/MedTech Dive
    Image attribution tooltip
    Dive Awards

    The MedTech Dive Awards of 2019

    From TAVR's takeoff to FDA's new approaches to premarket review, these are the industry forces that left their mark on medical technology this year.

    Dec. 9, 2019
  • Dive Awards

    Disruption of the Year: EU MDR notified bodies shortage

    The new European Union Medical Device Regulation requires more devices to undergo notified body review than ever before. But there are worries there aren't enough notified bodies to handle the workload.

    By Dana Elfin • Dec. 9, 2019
  • A sign reading Food and Drug Administration hangs over a building entrance.
    Image attribution tooltip

    Yujin Kim / MedTech Dive, original photo courtesy of U.S. Food and Drug Administration

    Image attribution tooltip
    Dive Awards

    Regulatory Development of the Year: 510(k) changes inch along

    New efforts by FDA to build out the program come years after the Institute of Medicine recommended scrapping it. More than 80% of devices are cleared through the pathway, so small changes can be meaningful to product safety.

    By David Lim • Dec. 9, 2019
  • EPA wants more data from ethylene oxide sterilizers, strikes device-friendly tone

    Administrator Andrew Wheeler said "medical device sterilization is vital to protecting public health" on release of a notice ahead of rulemaking that could impact sterilizers reliant on the carcinogenic gas.

    By David Lim • Dec. 6, 2019
  • FDA grades new Medtronic SynchroMed II recall as Class I event

    The voluntary move is the latest in a series of safety actions involving the implantable drug infusion pump, which was the focus of a 2015 consent decree between the company and the government.

    By Updated Dec. 10, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    Vicarious' surgical robot gets FDA breakthrough status

    The company also announced Scott Huennekens, former CEO of Google and Johnson & Johnson's robotic surgery joint venture, joined its board of directors.

    By Dec. 5, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Sens. Wyden, Booker push CMS, FTC, insurers on bias in algorithms

    The lawmakers want an investigation into how use of the algorithms may lead to discrimination against marginalized populations.

    By Dec. 4, 2019
  • EU Parliament panel adopts MDR delay for some Class I devices, full nod likely

    One committee member called out the unusual nature of making late-in-the-game substantive regulatory changes through the corrigendum, a procedure typically meant for correcting technicalities and inconsistencies.

    By Dana Elfin • Dec. 4, 2019
  • FDA commissioner nominee backs 'proactive, not passive' approach to device safety

    While Stephen Hahn shed more light on his thoughts on certain medical device topics, he declined to say FDA scientific judgments of medical devices should be held to the same regulatory standards as drugs in response to a question. 

    By David Lim • Dec. 4, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Hospitals sue HHS, warning price transparency rule would chill competition, crash computers

    An agency spokeswoman shot back that hospitals "should be ashamed that they aren't willing to provide American patients the cost of a service before they purchase it."

    By Samantha Liss • Dec. 4, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Contract sterilizer of devices draws FDA warning over validation issues

    American Contract Systems received multiple complaints about the presence of foreign matter in sealed sterilization bags, the agency said.

    By Dec. 4, 2019
  • FDA approves TB test from Qiagen and DiaSorin

    The approval could be a win-win for both companies, bringing Qiagen's TB blood test to DiaSorin's ​Liaison immunoassay analyzers while expanding the testing menu for Liaison. 

    By Dec. 2, 2019
  • With 6 months until new EU medical device rules, what's the state of play?

    Preparing for the May 26, 2020, implementation of the EU's Medical Device Regulation hasn't been easy, given the lack of notified bodies designated to review devices under the more stringent standards.

    By Dana Elfin • Updated Nov. 26, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Mandatory CMS radiation oncology model goes on the backburner

    Originally, the agency was eying an implementation date as early as Jan. 1, but the new regulatory agenda lists July 2022 as a target date for the bundled payment model. 

    By David Lim • Nov. 26, 2019
  • FDA launches pilot to speed new ethylene oxide sterilization methods

    Device makers should also reduce paper in packaging "as soon as possible" to trim the amount of the gas required for effective sterilization. The agency also named its innovation challenge winners.

    By David Lim • Nov. 25, 2019
  • AdvaMed lobbied EPA chief Wheeler on cancer report amid delay in ethylene oxide regs

    A bipartisan congressional task force is pushing EPA to issue ethylene oxide regulations that rely on EPA's 2016 report on the toxicity of the gas.

    By David Lim • Nov. 22, 2019
  • Medtronic's recovering DCB segment scores FDA approval of IN.PACT AV

    The approval allows Medtronic to sell the paclitaxel-coated balloon as a treatment for failing arteriovenous access in dialysis patients.

    By Nov. 22, 2019
  • Rare medical device ban, OTC hearing aids make FDA year-end to-do list

    Medical device manufacturers concerned about a federal crackdown on commercial ethylene oxide sterilizers can breathe a sigh of relief as the EPA says a timeline for final regulations remains to be determined.

    By David Lim • Nov. 21, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Transcatheter device to treat heart failure gets breakthrough designation

    BioVentrix is enrolling 120 subjects in a clinical trial meant to support U.S. marketing authorization for its minimally invasive alternative to conventional surgical ventricular reconstruction.

    By Nov. 21, 2019
  • Trump FDA nominee Hahn advanced by Senate HELP Committee 18-5

    Ranking Member Patty Murray said she would not support the nomination due to a lack of a commitment to back regulations to take non-tobacco flavored e-cigarettes that have not gone under FDA review off the market. 

    By David Lim • Updated Dec. 3, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Carolina Liquid gets FDA warning over sale of unauthorized reagents

    FDA said Carolina Liquid distributed Class I and II IVD reagents without regulatory clearance. The warning is the latest in a series of letters issued this year to companies for distributing devices without premarket approval. 

    By Nov. 20, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    AdvaMed wants FDA to define 'significantly' improved for Safer Technologies Program eligibility

    Although the trade association said it supports efforts to speed safer medical devices to market, it believes the agency's draft guidance lacks the specificity needed for industry to understand which devices would be eligible.

    By David Lim • Nov. 19, 2019